Both tirzepatide and Mounjaro represent groundbreaking approach to treating type 2 diabetes and obesity. This medication is a dual receptor activator that targets multiple hormone pathways, specifically GLP-1 and https://janemlce659968.jaiblogs.com/70966009/understanding-the-drug-this-brand-what-readers-must-for-understand